Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 1, 1997, Pages 91-98

  Segawa, Yoshihiko ^a   Takigawa, Nagio ^a   Kataoka, Masaaki ^a   Takata, Ichiro ^a,b   Fujimoto, Nobukazu ^a,b   Ueoka, Hiroshi ^b  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Combined chemoradiation therapy; Combined modality therapy; Hyperfractionated radiation therapy; Lung cancer; Radiation pneumonitis; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030870077     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00297-6     Document Type: Article

References (21)

1. Anscher, M. S.; Murase, T.; Prescott, D. M.; Marks, L. B.; Reisenbichler, H.; Bentel, G. C.; Spencer, D.; Sherouse, G.; Jirtle, R. L. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 30:671-676; 1994.
2. Arriagada, R.; Le Chevalier, T. Combined modalities in small-cell lung cancer. In: Johnson, B. E., Johnson, D. H., eds. Lung cancer. New York: Wiley-Liss Inc.; 1995:263-280.
3. Bennett, D. E.; Million, R. R.; Ackermann, L. V. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma (report and analysis of seven cases with autopsy). Cancer 23:1001-1018; 1969.
4. Boring, C. C.; Squires, T. S.; Tong, T. Cancer statistics. Cancer 43:7-26; 1993.
5. Cox, J. D.; Azarnia, N.; Byhardt, R. W.; Shin, K. Y.; Emami, B.; Pajak, T. F. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥ 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
6. Cox, J. D.; Stetz, J.; Pajak, T. F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Bio. Phys, 31:1341-1346; 1995.
7. Ginsberg, R. J.; Kris, M. G.; Armstrong, J. G. Cancer of the lung: Non-small cell lung cancer. In: DeVita, V. T.; Hellman, S.; Rosenberg, S., eds. Cancer: Principles & practice of oncology, 4th ed. Philadelphia: Lippincott Co; 1993:676-723.
8. Ginsberg, S. J.; Comis, R. L. The pulmonary toxicity of antineoplastic agents. Semin. Oncol. 9:34-51; 1982.
9. Gould, C.; Sause, W. T. Radiation therapy for lung cancer. In: Johnson, B. E.; Johnson, D. H., eds. Lung cancer. New York: Wiley-Liss Inc.; 1995:191-207.
10. Hazuka, M. B.; Gandara, D.; Turrisi, A. T. Combined chemotherapy and radiotherapy in the nonsurgical treatment of stage III nonsmall-cell lung cancer. In: Johnson, B. E.; Johnson, D. H., eds. Lung cancer. New York: Wiley-Liss Inc.; 1995:231-245.
11. Kataoka, M.; Kawamura, M.; Itoh, H.; Hamamoto, K. Ga67 citrate scintigraphy for the detection of radiation pneumonitis. Clin. Nucl. Med. 17:27-31; 1992.
12. Kohno, N.; Hamada, H.; Fujioka, S.; Hiwada, K.; Yamakido, M.; Akiyama, M. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102:117-122; 1992.
13. Kuroishi, T.; Hayakawa, N.; Kurihara, M.; Aoki, K. Cancer mortality in 33 countries of the world (1953-1987). In: Tominaga, S.; Aoki, K.; Fujimoto, I.; Kurihara, M., eds. Cancer mortality and morbidity statistics: Japan and the World - 1994. Tokyo: Japan Scientific Society Press; 1994:167-230.
14. Marino, P.; Preatoni, A.; Cantoni, A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stage Ilia and IIIb nonsmall cell lung cancer. Cancer 76:593-601; 1995.
15. Mountain, C. F. A new international staging system for lung cancer. Chest 89:225S-233S; 1986.
16. Ohnoshi, T.; Hiraki, S.; Ueoka, H.; Kiura, K.; Kamei, H.; Horiguchi, T.; Kodani, T.; Maeda, T.; Tabata, M.; Shibayama, T.; Segawa, Y.; Miyatake, K.; Takigawa, N.; Kimura, I. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer. Cancer 72:1597-1601; 1993.
17. Phillips, T. L. Effects of chemotherapy and irradiation on normal tissues. In: Meyer, J. L.; Vaeth, J. M., eds. Radiotherapy/chemotherapy interactions in cancer therapy: Frontiers in radiation therapy oncology. Basel: Karger; 1992:45-54.
18. Pignon, J. P.; Arriagada, R.; Ihde, D. C.; Johnson, D. H.; Perry, M. C.; Souhami, R. L.; Brodin, O.; Joss, R. A.; Kies, M. S.; Lebeau, B.; Ohnoshi, T.; Østerlind, K.; Tattersall, M. H. N.; Wanger, H. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N. Engl. J. Med. 327:1618-1624; 1992.
19. Roach, M., III; Gandara, D. R.; Yuo, H.; Swift, P. S.; Kroll, S.; Shrieve, D. C.; Wara, W. M.; Margolis, L.; Phillips, T. L. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J. Clin. Oncol. 13:2606-2612; 1995.
20. Roswit, B.; White, D. C. Severe radiation injuries of the lung. AJR 129:127-136; 1977.
21. World Health Organization histological typing of lung tumours, 2nd ed. Am. J. Clin. Pathol. 77:123-136; 1982.